Efficacy and Safety of Ruxolitinib Cream Among Children With Atopic Dermatitis Aged 2 to 6 Years and 7 to <12 Years: Results from a Phase 3 Double-Blind Vehicle-Controlled Study

Authors

Andrea Zaenglein MD

Publication/Presentation Date

2-2024

Volume

153

Issue

2

First Page

1

Last Page

1

Published In/Presented At

https://doi.org/10.1016/j.jaci.2023.11.027

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine Faculty

Document Type

Article